A first patient has been dosed in a Phase 1b trial evaluating the safety and efficacy of GMA301, an…
Articles by Forest Ray PhD
Janssen Pharmaceutical has asked the U.S. Food and Drug Administration (FDA) to approve the use of intravenous Uptravi (selexipag) by…
Rare variants of the ABCC8 gene were found among pulmonary arterial hypertension (PAH) patients in Spain, a study…
Delayed diagnosis, limited resources, and a lack of awareness compound barriers to care for people with pulmonary hypertension (PH)…
Note: This story was updated Sept. 28, 2020, to clarify that Uptravi was being tested as part of an initial…
Using sildenafil and milrinone together proved more effective than either therapy alone in treating newborns with severe persistent…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…
High levels of the peptide adiponectin show potential as a biomarker for the prognosis of congenital heart…
Aerovate Therapeutics received $72.6 million in Series A funding to advance trials testing AV-101, an experimental…
Pregnant women with pulmonary arterial hypertension (PAH) should seek specialist care before giving birth and for months afterward, due…
A protein called interleukin-32 may serve as a biomarker for pulmonary arterial hypertension (PAH) in scleroderma patients, for whom…